-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Wedbush Research Analysts Cut Earnings Estimates for MLTX
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Investment analysts at Wedbush cut their Q1 2025 earnings per share (EPS) estimates for MoonLake Immunotherapeutics in a research note issued on Wednesday, February 26th. Wedbush analyst Y. Zhong now forecasts that the company will post earnings per share of ($0.76) for the quarter, down from their prior […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Investment analysts at Wedbush cut their Q1 2025 earnings per share (EPS) estimates for MoonLake Immunotherapeutics in a research note issued on Wednesday, February 26th. Wedbush analyst Y. Zhong now forecasts that the company will post earnings per share of ($0.76) for the quarter, down from their prior […]
